Try our beta test site
79 studies found for:    Open Studies | "Urinary Bladder, Overactive"
Show Display Options
Rank Status Study
21 Recruiting Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence
Conditions: Urinary Bladder, Overactive;   Urinary Incontinence
Interventions: Biological: onabotulinumtoxinA;   Drug: Placebo (saline)
22 Not yet recruiting Low-level Light Therapy for Overactive Bladder and Urinary Incontinence
Conditions: Overactive Bladder;   Urinary Incontinence
Interventions: Device: Low-level light therapy;   Device: Placebo
23 Not yet recruiting Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)
Condition: Urinary Bladder, Overactive
Intervention: Biological: onabotulinumtoxinA
24 Recruiting A Study of Transcutaneous Electrical Nerve Stimulation for Overactive Bladder
Conditions: Urge Incontinence;   Overactive Bladder
Intervention: Device: Transcutaneous Electrical Nerve Stimulation
25 Recruiting Gene Expression in the Overactive Bladder in Children
Conditions: Overactive Bladder;   Children
Intervention:
26 Recruiting "The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
Conditions: Overactive Bladder;   Caffeine;   Menopause
Interventions: Dietary Supplement: 400 mg of caffeine/day (Two 200mg pills/day);   Dietary Supplement: 200 mg of caffeine/day (One 200mg pill and one placebo pill);   Dietary Supplement: Two placebo pills/day
27 Recruiting Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OAB
Condition: Overactive Bladder
Interventions: Drug: Dried Cranberry;   Drug: Placebo Oral Capsule
28 Recruiting Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
Conditions: Overactive Bladder;   Bladder Cancer;   Synergo
Intervention: Other: Questionnaires, anticholinergic treatment, urodynamic study
29 Not yet recruiting Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.
Conditions: Overactive Bladder;   Benign Prostatic Hyperplasia
Interventions: Drug: Mirabegron;   Drug: Tamsulosin
30 Recruiting Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
Condition: Overactive Bladder Syndrome
Interventions: Drug: Solifenacin for 12 weeks;   Drug: Solifenacin for 24 weeks
31 Recruiting A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)
Condition: Overactive Bladder
Interventions: Drug: Mirabegron;   Drug: Placebo
32 Recruiting Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder
Conditions: Overactive Bladder;   Urge Urinary Incontinence
Intervention: Drug: Bryophyllum
33 Recruiting OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: OnabotulinumtoxinA
34 Recruiting Time of Effect Onset in Treating Overactive Bladder or Non Obstructive Urinary Retention by Sacral Neuromodulation
Conditions: Overactive Bladder;   Non Obstructive Urinary Retention
Intervention: Behavioral: Filling out voiding diaries.
35 Recruiting Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity
Condition: Urinary Bladder, Overactive
Interventions: Drug: GSK1358820;   Drug: Placebo
36 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Urinary Bladder Overactive;   Overactive Bladder;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
37 Recruiting Specified Drug Use-results Survey of Betanis Tablets
Condition: Overactive Bladder
Intervention: Drug: Betanis
38 Recruiting The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair
Conditions: Overactive Bladder;   Pelvic Organ Prolapse
Intervention:
39 Recruiting Phase 1 Study in Subjects With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer
Condition: OAB (Overactive Bladder Syndrome and Detrusor Overactivity)
Interventions: Drug: Placebo (PBS-20% sucrose);   Drug: hMaxi-K
40 Recruiting OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER
Condition: Overactive Bladder
Interventions: Drug: onaBoNT-A;   Drug: Oxybutynin ER

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.